I have followed Medical Marijuana, Inc. (MJNA) closely for 9 months.  It has been a story that has disgusted me as far as the lack of transparency and the poor corporate governance but also one that has offered hope, as the company seemed poised to capitalize on cannabis despite all these short-comings.  Specifically, the company is able to ship CBD-based products derived from hemp to any consumer in the U.S. or even beyond.

I shared my most recent update at Seeking Alpha in an article that examined several issues that arose  in the most recent quarterly filing.  I submitted that article on Saturday 11/16, a day after the company had sneaked in its quarterly filing a day late and after the market had closed.  I published with the caveat that the company hadn't yet released a press release.  Today, almost four full trading sessions later, the company did so, and you can access it here. The p.r. lacked substance, failing to address why board members left (to go back to agriculture???) or why the company had turned to outside financing when CannaBank was supposedly capable of funding the company.  Why did the company still not sell the 47mm shares allocated to fund research (and change the time-frame from three years to up to five years).

Rather than raise the points I have already addressed, I want to point to new issues that have arisen subsequently, all of which we have discussed at length on 420 Investor, the best place to learn about publicly-traded cannabis stocks.

1. CannaVest actually has begun selling shares at $1 (1.2mm)
2. The company didn't address most all of the issues I have discussed
3. "Wellness Services" was mentioned as shut-down.  This is at odds with the OTC filing and also points to misrepresentations made in press releases ...

One of the stocks that I have been warning folks about for several months is AVT, Inc. (AVTC).  So far, I believe that my warnings have been not only helpful but for the right reasons.  Here is the chart:

I ...

One thing 2013 has taught cannabis investors is that not all pot stocks are the same.  At 420 Investor, one of our goals is to separate the proverbial flower from the stem as we identify the companies that have potential ...

420 Investor had the great pleasure of hosting Jamen Shively, founder of Diego Pellicer, for two fascinating webinars.  One our four pillars of our service is to bring our subscribers outside experts and industry leaders, and we started at the ...

For all you MJNA fans, I just got an email from HempMedsPx - with a broken link!  Still, one can get to the order site.  Here is the first offering, and it's a Dixie Botanical knock-off, as I had ...

Good news:  My mCig just arrived

Bad news:  I really have no idea what to do with it!

Here it how the package looks:

The instructions on the back have misspellings and are missing some letters on the far right ...

One of the biggest misconceptions in the cannabis investing sector is the belief that Medical Marijuana, Inc. (MJNA) acquired the Colorado-based Dixie Elixirs & Edibles in 2012.  Nothing could be further from the truth.  If you already know this, then ...

Earlier this week, I was approached by Paul Rosenberg, CEO of mCig, which recently reverse merged with Lifetech Industries.  He was impressed with my interview of Sterling Scott   CEO of GrowLife (PHOT), and wanted to tell me his story. ...

I was quoted in a recent article examining the FINRA warning on pot stocks:

"That is the message of FINRA: Be careful. There are people out there that are focused on marijuana stocks because they are hot," says Alan Brochstein, ...

If you are like me and think that the rapidly changing regulatory landscape and public opinion about marijuana will unleash tremendous investment opportunities, then you want to understand the players, the challenges they face and the potential rewards to those ...